TUBB4A
Basic information
Region (hg38): 19:6494319-6502848
Previous symbols: [ "TUBB4", "DYT4" ]
Links
Phenotypes
GenCC
Source:
- hypomyelinating leukodystrophy 6 (Moderate), mode of inheritance: AD
- torsion dystonia 4 (Strong), mode of inheritance: AD
- torsion dystonia 4 (Supportive), mode of inheritance: AD
- hypomyelinating leukodystrophy 6 (Supportive), mode of inheritance: AD
- hypomyelinating leukodystrophy 6 (Definitive), mode of inheritance: AD
- torsion dystonia 4 (Strong), mode of inheritance: AD
- hypomyelinating leukodystrophy 6 (Strong), mode of inheritance: AD
- TUBB4A-related neurologic disorder (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Dystonia 4, torsion, autosomal dominant; Leukodystrophy, hypomyelinating, 6 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 3156966; 23582646; 23595291; 24013879; 24526230; 24742798; 24850488; 25085639 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hypomyelinating leukodystrophy 6 (10 variants)
- not provided (7 variants)
- 6 conditions (1 variants)
- Auditory neuropathy spectrum disorder (1 variants)
- Hypomyelinating leukodystrophy 6;Torsion dystonia 4 (1 variants)
- Torsion dystonia 4 (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TUBB4A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 91 | 102 | ||||
missense | 11 | 25 | 67 | 107 | ||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 5 | 6 | |||
non coding | 13 | 22 | 43 | |||
Total | 11 | 25 | 84 | 108 | 28 |
Variants in TUBB4A
This is a list of pathogenic ClinVar variants found in the TUBB4A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-6494360-G-C | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Apr 27, 2017) | ||
19-6494364-C-T | Torsion dystonia 4 • Hypomyelinating leukodystrophy 6 | Uncertain significance (Apr 28, 2017) | ||
19-6494372-G-A | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Uncertain significance (Jan 13, 2018) | ||
19-6494439-C-T | Torsion dystonia 4 • Hypomyelinating leukodystrophy 6 | Benign (Jan 12, 2018) | ||
19-6494464-A-T | Torsion dystonia 4 • Hypomyelinating leukodystrophy 6 | Benign (Apr 27, 2017) | ||
19-6494491-T-C | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Apr 27, 2017) | ||
19-6494531-G-T | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Jan 13, 2018) | ||
19-6494537-T-G | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Uncertain significance (Jan 13, 2018) | ||
19-6494585-G-A | Torsion dystonia 4 • Hypomyelinating leukodystrophy 6 | Uncertain significance (Jan 12, 2018) | ||
19-6494671-G-C | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Jan 12, 2018) | ||
19-6494724-G-A | Torsion dystonia 4 • Hypomyelinating leukodystrophy 6 | Uncertain significance (Jan 12, 2018) | ||
19-6494735-G-A | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Jan 13, 2018) | ||
19-6494764-C-T | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Feb 26, 2021) | ||
19-6494860-G-A | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Uncertain significance (Jan 13, 2018) | ||
19-6494904-C-G | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Jun 19, 2018) | ||
19-6495053-C-G | Torsion dystonia 4 • Hypomyelinating leukodystrophy 6 | Benign (Jun 26, 2018) | ||
19-6495064-C-T | Torsion dystonia 4 • Hypomyelinating leukodystrophy 6 | Benign (Jan 13, 2018) | ||
19-6495068-G-C | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Jul 06, 2018) | ||
19-6495078-C-T | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Uncertain significance (Jan 13, 2018) | ||
19-6495095-G-C | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Apr 27, 2017) | ||
19-6495111-C-T | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Likely benign (Apr 27, 2017) | ||
19-6495128-G-C | Hypomyelinating leukodystrophy 6 • Torsion dystonia 4 | Benign (Jan 13, 2018) | ||
19-6495161-A-G | not specified • Torsion dystonia 4 • Hypomyelinating leukodystrophy 6 | Benign (Jan 12, 2018) | ||
19-6495168-G-A | Hypomyelinating leukodystrophy 6 | Uncertain significance (Aug 15, 2022) | ||
19-6495170-C-T | Hypomyelinating leukodystrophy 6 | Conflicting classifications of pathogenicity (Oct 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TUBB4A | protein_coding | protein_coding | ENST00000264071 | 4 | 8530 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.109 | 0.885 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.26 | 93 | 301 | 0.309 | 0.0000234 | 2941 |
Missense in Polyphen | 33 | 124.5 | 0.26505 | 1288 | ||
Synonymous | -1.48 | 159 | 137 | 1.16 | 0.0000125 | 877 |
Loss of Function | 2.41 | 4 | 13.6 | 0.294 | 5.95e-7 | 148 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000167 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.;
- Disease
- DISEASE: Dystonia 4, torsion, autosomal dominant (DYT4) [MIM:128101]: A form of torsion dystonia, a disease defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. 'Torsion' refers to the twisting nature of body movements, often affecting the trunk. DYT4 is characterized by onset in the second to third decade of progressive laryngeal dysphonia followed by the involvement of other muscles, such as the neck or limbs. Some patients develop an ataxic gait. {ECO:0000269|PubMed:23424103}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukodystrophy, hypomyelinating, 6 (HLD) [MIM:612438]: A neurologic disorder characterized by onset in infancy or early childhood of delayed motor development and gait instability, followed by extrapyramidal movement disorders, such as dystonia, choreoathetosis, rigidity, opisthotonus, and oculogyric crises, progressive spastic tetraplegia, ataxia, and, more rarely, seizures. Most patients have cognitive decline and speech delay, but some can function normally. Brain MRI shows a combination of hypomyelination, cerebellar atrophy, and atrophy or disappearance of the putamen. {ECO:0000269|PubMed:23582646}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Phagosome - Homo sapiens (human);Gap junction - Homo sapiens (human);Pathogenic Escherichia coli infection - Homo sapiens (human);Pathogenic Escherichia coli infection;Parkin-Ubiquitin Proteasomal System pathway;Post-translational protein modification;Metabolism of proteins;Chaperonin-mediated protein folding;Formation of tubulin folding intermediates by CCT/TriC;Carboxyterminal post-translational modifications of tubulin;Regulation of PLK1 Activity at G2/M Transition;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Protein folding;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Prefoldin mediated transfer of substrate to CCT/TriC;Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding;Post-chaperonin tubulin folding pathway;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.76
- rvis_percentile_EVS
- 13.33
Haploinsufficiency Scores
- pHI
- 0.388
- hipred
- Y
- hipred_score
- 0.501
- ghis
- 0.626
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tubb4a
- Phenotype
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;microtubule cytoskeleton organization;mitotic cell cycle;microtubule-based process;regulation of G2/M transition of mitotic cell cycle;negative regulation of microtubule polymerization;ciliary basal body-plasma membrane docking
- Cellular component
- nucleus;cytoplasm;cytosol;microtubule;axoneme;internode region of axon;neuronal cell body;myelin sheath;extracellular exosome
- Molecular function
- GTPase activity;structural constituent of cytoskeleton;calcium ion binding;protein binding;GTP binding